Spironolactone
Product Images NDC 53217-356

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Spironolactone (NDC 53217-356). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aidarex Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Spironolactone 100mg 1)

Chemical structure of Spironolactone, showing its steroid backbone with attached lactone and acetate functional groups as depicted in the diagram.*

FDA Label Image

Figure 1. Survival By Treatment Group In The Randomized Spironolactone Evaluation Study (Spironolactone 100mg 2)

A Kaplan-Meier survival curve comparing Spironolactone with placebo over 48 months. The graph shows probability on the vertical axis and months on the horizontal axis. Two lines represent Spironolactone (n=822) and placebo (n=841), with a statistically significant difference (log-rank p < 0.001).*

FDA Label Image

Figure 2. Hazard Ratios Of All-cause Mortality By Subgroup In The Randomized Spironolactone Evaluation Study (Spironolactone 100mg 3)

A forest plot showing hazard ratios (HR) and 95% confidence intervals (CI) across various subgroups, including age, sex, race, LVEF, heart failure type, NYHA class, diabetes status, serum creatinine, creatinine clearance, potassium levels, digoxin use, ACE inhibitor use, and beta blocker use. The plot compares Spironolactone versus placebo effectiveness, with HR values plotted along a horizontal axis indicating Spironolactone benefit on the left and placebo benefit on the right.*

FDA Label Image

53217-0356_spironolactone_100mg (Spironolactone 100mg 4)

Spironolactone USP 100 mg film-coated tablets, package of 30 tablets, labeled by Aidarex Pharmaceuticals LLC. The label includes proprietary name, strength, dosage form, tablet count, NDC 53217-356, and manufacturing information for Mfg: Intas Pharmaceuticals Limited, India.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.